What's new
Fantasy Football - Footballguys Forums

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

***OFFICIAL CYDY/Leronlimab Thread*** (3 Viewers)

If you believe in lenzilumab enough to invest in HGEN, then you have to admit that leronlimab has potential.  The interim analysis of S/C could produce great results.  The stock could skyrocket if the placebo arm has more deaths than the treatment arm despite having half as many patients.  And that is a possibility.  The best part is that stock won't tank if the results are mediocre because the truthers won't accept that the results are actually mediocre.
You were good until the last sentence.  If they don't get a Covid approval, I think it tanks.  Hopefully they get this BLA on track for HIV though, that would help.

 
This brings us to the end of yet another session of Weekly Troll Talk. 

Stay tuned next week at the same time as we hear more gloating after the latest short attack.
The timing of him showing back up was something to behold.

Still not convinced he's not the Night King but either way, they have some things in common.

 
I think they can potentially both be winners here.
Yep.  This isn't Highlander.  There can be more than one.  And there will be more than one Covid drug this fall/winter/spring because no drug is showing that it can deal with Covid entirely.  A bunch of drugs are showing that they might help a bit.  A lot of patients will receive several different drugs.  Leronlimab is a no-brainer choice for any Covid patient because it is 100% safe and mild.  And it will help.

 
Last edited by a moderator:
Samantha Mottet will be on Dr. Yo's show next week

She's the lady from April that keeps popping up on local news outlets as a LL success story.  

This will move the needle... this is the time... this is the one... this one... this time.   :oldunsure:
Meh.  We've heard this story and I'm happy she's healthy.  I don't think she's a great interview from what I've seen.   Surprised Dr Yo is digging this one back up, we need some new stories not recycled stuff.

 
These posts always kill me.
My bad.  I guess I should have saw this one coming.  Patterson boasting about Operation Warp Speed, the Wall Street Journal outing it as a fabrication.  

Timing was awful for sure.  I won't make any more predictions for stock price, one thing for sure, you can never predict what is going to happen with this company.

@Don Hutson, the question stands, are you buying again?  Nice call BTW

 
Did Patterson just shoot off excited because he was in Hollywood?  He's not the guy I expect the stock price to go down for.  Worse than Nader this week.

I don't need well read publications coming down on this stock because one of their lead Dr consultants can't stop from pumping it.

Frustrating all around.  Nobody has any respect for this company and these are the reasons why.

 
Last edited by a moderator:
I was never in as early or as deep as many of you were. It was a fun run-up, even being late to the party. Of course I wish I had sold out higher, but when it kept going down I finally decided to take most of my shares off the table for a loss. Put them into another stock a friend turned me on to and so far I've gained back about half of my CYDY losses.

Still believe in the science of it all, and think the M/M study showed positive data about what LL can do. I've stated my (mild) concerns about how they present data, and while I think they have a good shot at really positive S/C results, I wonder if time is working against them here. Hopefully not. Still have enough shares in play that if it rocketships up to $30 I'll have enough gains as if I cashed out back when it was at $10. If I lose the rest, then so be it. Only started doing any stock investing back in March, and CYDY gave me a hell of an entry education, and has been a crazy ride. 

 
Nothing new really, just an explanation on why Forbes pulled the plug-

@TomLandstreet

1) Forbes took my post on $CYDY Leronlimab down because they viewed my statements regarding the @realDonaldTrump presser misleading.

I greatly appreciate all of the tremendous support I've received over the last few days. I continue to believe deeply in Leronlimab.

(2) I wrote the article because I, like many of you, have been tremendously disappointed by the government's response to Covid-19.

I've done my work on HCQ, Remdesivir $GILD, and Plasma. No treatment on the market even comes close to Leronlimab re efficacy. AND it's safe. $cydy

(3) It's time for our officials to approve Leronlimab for emergency usage - why should a patient die under standard of care when Leronlimab (with a perfect safety profile) could have saved them?

The drug WORKS

 
This is kind of interesting

3 BPs partnering for a trial targeting CCR5 (and CCR2)

https://www.takeda.com/newsroom/newsreleases/2020/members-of-the-covid-rd-alliance-and-quantum-leap-healthcare-collaborative-enroll-first-patients-in-i-spy-covid-trial/

Seems like there is something to what Leronlimab is doing.  When will it get some traction?  At least printed in a respected journal, please
Doesn't seem right. Pretty sure we were informed this is ancient stuff that was determined to not work by BP 20 years ago.

 
Thank you for the reply and i think a lot here agree on on the company side regarding timelines and promises. 

Regarding the drug, you've called it old a few times, but does this matter? Is it rare for drugs to be repurposed or to be bought by a different company a used slightly differently?

Surely CYDY isn't the only company with an "old drug" that they're trying to make work for covid, right?
You are 100% correct, old drugs for Covid make no difference. Dexamethazone is the perfect example here.

For HIV, research is advancing, it’s expected, but not guaranteed, that new drugs have an advantage.
Hi Bob

 
Hi Golf, I might need to do some statistical analysis before committing on odds.

I thought everyone In the FFA just welches on these bets anyway. How do I find that old thread?
@Aaron Rudnicki can lead you there and @Otis can hold the cash.  Me and Otis are not best friends by any means but I have paypaled him 10k before for bet and when the other guy backed out he sent it back.  Otis might be a lawyer but a scumbag he is not.

 
Last edited by a moderator:
I posted the below in the other thread back in April. 
 

Since I offered my opinion on CYDY I have followed the company closely. I’m also interested in and following COVID treatments.

My initial (high) skepticism resulted from:

I worked on development of a CCR5 Antagonist 20 or so years ago. Most big Pharma had a molecule (or more). It was described with so much promise, applications, etc. and then they almost all went away.
Draw no conclusions, though. Just a general fyi.

 
Sorry if I got a little triggered today, one of those WSJ guys has actually been emailing me.

Anything you want to say to any of these dudes? He usually responds.  

This guy definitely has it out for Patterson, doesn't trust him and infers he is compromised by his business interests with Cytodyn (paraphrasing a little but that's the gist).  He actually emailed me as soon as the article got posted and said something to the effect that I might not want to hear what Patterson had to say.

I've called them out on taking things out of context, he says I'm on a cult stock.

Not sure what else to say. It's weird that guys from the WSJ are this hell bent against this company but I also don't get the feeling they understand anything about the science either.  They are definitely following the Night King's lead here.  The whole thing is odd.  I asked them point blank if they had anything real with fraud to post it, of course crickets.

 
Golf Guy 69 said:
@Aaron Rudnicki can lead you there and @Otis can hold the cash.  Me and Otis are not best friends by any means but I have paypaled him 10k before for bet and when the other guy backed out he sent it back.  Otis might be a lawyer but a scumbag he is not.
He's not a real lawyer so the scumbag factor is low.

 
Sorry if I got a little triggered today, one of those WSJ guys has actually been emailing me.

Anything you want to say to any of these dudes? He usually responds.  

This guy definitely has it out for Patterson, doesn't trust him and infers he is compromised by his business interests with Cytodyn (paraphrasing a little but that's the gist).  He actually emailed me as soon as the article got posted and said something to the effect that I might not want to hear what Patterson had to say.

I've called them out on taking things out of context, he says I'm on a cult stock.

Not sure what else to say. It's weird that guys from the WSJ are this hell bent against this company but I also don't get the feeling they understand anything about the science either.  They are definitely following the Night King's lead here.  The whole thing is odd.  I asked them point blank if they had anything real with fraud to post it, of course crickets.
The WSJ is less relevant now than ever before, they are not the same as 10 plus years ago.

 
Sorry if I got a little triggered today, one of those WSJ guys has actually been emailing me.

Anything you want to say to any of these dudes? He usually responds.  

This guy definitely has it out for Patterson, doesn't trust him and infers he is compromised by his business interests with Cytodyn (paraphrasing a little but that's the gist).  He actually emailed me as soon as the article got posted and said something to the effect that I might not want to hear what Patterson had to say.

I've called them out on taking things out of context, he says I'm on a cult stock.

Not sure what else to say. It's weird that guys from the WSJ are this hell bent against this company but I also don't get the feeling they understand anything about the science either.  They are definitely following the Night King's lead here.  The whole thing is odd.  I asked them point blank if they had anything real with fraud to post it, of course crickets.
Big Pharma has long tentacles.

Also we need to dump the BP abbreviation because it covers Bruce Patterson and Big Pharma.  

 
Sorry if I got a little triggered today, one of those WSJ guys has actually been emailing me.

Anything you want to say to any of these dudes? He usually responds.  

This guy definitely has it out for Patterson, doesn't trust him and infers he is compromised by his business interests with Cytodyn (paraphrasing a little but that's the gist).  He actually emailed me as soon as the article got posted and said something to the effect that I might not want to hear what Patterson had to say.

I've called them out on taking things out of context, he says I'm on a cult stock.

Not sure what else to say. It's weird that guys from the WSJ are this hell bent against this company but I also don't get the feeling they understand anything about the science either.  They are definitely following the Night King's lead here.  The whole thing is odd.  I asked them point blank if they had anything real with fraud to post it, of course crickets.
You have my respect sir. Thank you for doing this. All we need is to get approved for some use and it shuts everybody up.....,. for a while.

 
It's really not that big a deal. The Eddie Haskell routine is just a little much.
I shared my lived experience, which is easily verified if you trust Wikipedia. Seemed relevant to the topic and informed my opinion, sorry you didn’t find it valuable.

https://en.m.wikipedia.org/wiki/CCR5_receptor_antagonist
 

As mentioned, the CCR5 receptor is a G-protein coupled receptor (GPCR). Before the discovery of CCR5's role in HIV infection, many pharmaceutical companies had already built a substantial collection of compounds that target GPCRs.[citation needed] Some of these compounds would prove to be a starting point for CCR5 antagonist medicinal chemistry, but would need optimization to improve CCR5 selectivity and potency, and to improve pharmacokineticproperties.[citation needed] A significant problem was the affinity of available screening hits for the hERG ion channel;[citation needed] inhibition of hERG leads to QT interval prolongation, which can increase the risk of developing fatal ventricular arrhythmias.[3][13] Many CCR5 antagonists have been studied by pharmaceutical companies, but few of them have actually reached human efficacy studies; for example AstraZeneca,[14][non-primary source needed]Novartis,[15][non-primary source needed]Merck,[16][non-primary source needed] and Takeda[17][non-primary source needed] have used their GPRC-targeting compound collections to develop a potent CCR5 antagonist, but none of them have reached clinical trials.[citation needed]Three pharmaceutical companies were in competition to be the first to have a small molecule CCR5 antagonist approved:[citation needed]GlaxoSmithKline (GSK) with their compound aplaviroc,[citation needed]Schering-Plough with vicriviroc,[citation needed] and Pfizer with maraviroc.[citation needed] All of the compounds reached clinical trials in humans;[citation needed] only maravirochas been approved[vague] by the U.S. Food and Drug Administration (FDA).[3]

 
Almost feels like this would be more fun just to root for this to go back to what I paid for it at this point.  Every day would feel like a win!

 

Users who are viewing this thread

Back
Top